Table 1

Treatment satisfaction scores

Treatment period (months)		OHA-Q subscale
		Treatment convenience (range: 0–27)			Somatic symptoms (range: 0–24)			Satisfaction (range: 0–9)
		N	Mean (SD)	p value	N	Mean (SD)	p value	N	Mean (SD)	p value
All patients
6		1146	21.9 (4.8)	−	1157	17.7 (4.2)	−	1156	6.5 (1.6)	−
12		1069	21.9 (4.7)	−	1087	17.7 (4.1)	−	1081	6.6 (1.6)	−
18		1013	21.8 (4.7)	−	1032	17.5 (4.1)	−	1024	6.6 (1.6)	−
24		997	21.8 (4.7)	−	1015	17.5 (4.2)	−	1007	6.6 (1.6)	−
HbA1c target attainment
6	Yes	405	22.3 (4.6)	0.0204	408	18.3 (4.0)	0.0008	409	6.6 (1.6)	0.0435
6	No	694	21.6 (4.8)		702	17.4 (4.3)		701	6.4 (1.6)
12	Yes	378	22.4 (4.8)	0.0280	386	17.9 (4.2)	0.2978	384	6.7 (1.6)	0.0636
12	No	640	21.7 (4.7)		649	17.7 (4.1)		645	6.5 (1.6)
18	Yes	359	22.5 (4.5)	0.0006	365	17.9 (4.3)	0.0310	360	6.7 (1.6)	0.0497
18	No	609	21.5 (4.7)		621	17.3 (4.0)		618	6.5 (1.6)
24	Yes	334	22.5 (4.4)	0.0026	344	18.1 (4.2)	0.0010	338	6.8 (1.5)	0.0002
24	No	598	21.5 (4.9)		607	17.1 (4.2)		606	6.4 (1.6)
Monotherapy
6	Yes	889	22.1 (4.7)	0.0020	898	17.9 (4.2)	0.0348	900	6.5 (1.6)	0.6882
6	No	257	21.1 (4.9)		259	17.2 (4.4)		256	6.4 (1.5)
12	Yes	758	22.3 (4.6)	0.0001	768	18.1 (4.2)	0.0001	769	6.6 (1.6)	0.0130
12	No	311	20.8 (5.0)		319	16.9 (3.8)		312	6.4 (1.5)
18	Yes	669	22.6 (4.4)	0.0001	678	17.9 (4.2)	0.0001	682	6.7 (1.6)	0.0003
18	No	344	20.3 (4.8)		354	16.8 (3.8)		342	6.3 (1.5)
24	Yes	614	22.4 (4.6)	0.0001	624	17.8 (4.4)	0.0002	623	6.7 (1.6)	0.0036
24	No	383	20.7 (4.8)		391	16.9 (3.9)		384	6.4 (1.5)